Cargando…

The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II–III Colorectal Cancer Patients After Curable Resection

BACKGROUND: Smoldering cancer-related inflammation attenuates chemotherapy efficacy and contributes to unsatisfactory outcome for patients of colorectal cancer (CRC). Various inflammation-based biomarkers were reported to predict the survival of the disease, however, it remains unclear which is the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ying, Hou-Qun, Liao, Yu-Cui, Sun, Fan, Peng, Hong-Xin, Cheng, Xue-Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822081/ https://www.ncbi.nlm.nih.gov/pubmed/33500648 http://dx.doi.org/10.2147/JIR.S285129

Ejemplares similares

Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I–III Mucinous Colorectal Adenocarcinoma
por: Liao, Yu-Cui, et al.
Publicado: (2021)

Impact of Conversion on Short and Long-Term Outcome in Laparoscopic Resection of Curable Colorectal Cancer
por: White, Ian, et al.
Publicado: (2011)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
por: Posch, Florian, et al.
Publicado: (2017)

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer
por: Xin, Cheng, et al.
Publicado: (2023)

Peritoneal recurrence after resection for Stage I–III colorectal cancer: A population analysis
por: Aiken, Taylor, et al.
Publicado: (2022)

On the Curable Stage of Phthisis
por: Smith, Edward
Publicado: (1857)

Is Cancer Curable?
por: Gibbs, E. H.
Publicado: (1875)

Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer
por: Yuan, Zhen, et al.
Publicado: (2022)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

The Curability of Cancer by Erysipelas
Publicado: (1893)

Transmissibility and Curability of Cancer
por: Bainbridge, William Seaman
Publicado: (1907)

Transmissibility and Curability of Cancer
Publicado: (1907)

Transmissibility and Curability of Cancer
Publicado: (1907)

Frailty is an independent risk factor for recurrence and mortality following curative resection of stage I–III colorectal cancer
por: Mima, Kosuke, et al.
Publicado: (2020)

Hypomethylation-Associated Up-Regulation of TCF3 Expression and Recurrence in Stage II and III Colorectal Cancer
por: Li, Chunxiang, et al.
Publicado: (2014)

Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing
por: Kishigami, Fumishi, et al.
Publicado: (2022)

Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients
por: Sun, Fan, et al.
Publicado: (2018)

An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer
por: Cai, Du, et al.
Publicado: (2023)

The Prognosis and Recurrence Pattern of Right- and Left-Sided Colon Cancer in Stage II, Stage III, and Liver Metastasis After Curative Resection
por: Nakamura, Yasuyuki, et al.
Publicado: (2021)

Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer
por: Cavalleri, Tommaso, et al.
Publicado: (2022)

Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trial
por: Hansdotter, P, et al.
Publicado: (2021)

Diagnostic Accuracy of Elevated Serum Carcinoembryonic Antigen for Recurrence in Postoperative Stage II Colorectal Cancer Patients: Comparison With Stage III
por: Kim, Ho Seung, et al.
Publicado: (2013)

Why Early Cancer Is Curable
Publicado: (1917)

The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
por: Xu, Guozeng, et al.
Publicado: (2021)

Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
por: Li, Wanlu, et al.
Publicado: (2017)

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2018)

Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
por: Viñal, David, et al.
Publicado: (2022)

Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer
por: Mo, Shaobo, et al.
Publicado: (2020)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Vitamin D Status and Survival in Stage II-III Colorectal Cancer
por: Bao, Yichao, et al.
Publicado: (2020)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer
por: Ma, Min, et al.
Publicado: (2019)

Desmoplasia Influenced Recurrence of Disease and Mortality in Stage III Colorectal Cancer within Five Years after Surgery and Adjuvant Therapy
por: Zippi, Maddalena, et al.
Publicado: (2017)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages
por: Beaulieu, Jean-François, et al.
Publicado: (2016)

Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment
por: Wang, Fulong, et al.
Publicado: (2023)

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
por: Gruenberger, Birgit, et al.
Publicado: (2008)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer
por: Grancher, Adrien, et al.
Publicado: (2022)

Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer
por: Kawamura, Junichiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3u7ipvidt1qev1o5ijem1ruc6u